Phenobarbital has shown potential in the management of alcohol withdrawal syndrome (AWS), particularly as an adjunct or monotherapy alternative to benzodiazepines. However, there is a lack of standardized protocols for its use in the inpatient setting, making it difficult for clinicians to confidently integrate phenobarbital into inpatient care where benzodiazepines may be ineffective or fail. This presentation discusses the pathophysiology of alcohol withdrawal, and the pharmacology of benzodiazepines and phenobarbital; then, the presentation evaluates the available primary literature on phenobarbital use as an alternative first-line agent, its efficacy and safety of, and highlights key recommendations based on the studies available and the current Ascension Texas protocol.
- Provider:Ascension
- Activity Link: https://ascension-ce-cme.cloud-cme.com/
- Start Date: 2024-11-08 06:00:00
- End Date: 2024-11-08 06:00:00
- Credit Details: IPCE Credits: 0.75 hours
AAPA Category 1 Credit™️: 0.75 hours
AMA PRA Category 1 Credit™️: 0.75 hours
Nursing: 0.75 hours
Pharmacy: 0.75 hours - MOC Credit Details: ABS - 0.75 Point; Credit Type(s): Accredited CME (ABS)
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: General Surgery